agilon health, inc. Receivables, Net, Current
agilon health, inc. (AGL) had Receivables, Net, Current of $1.06 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2026-08-05
- 2026-06-30: Receivables, Net, Current $1.06B.
- 2026-03-31: Receivables, Net, Current $899.75M.
- 2025-12-31: Receivables, Net, Current $673.79M.
- 2025-09-30: Receivables, Net, Current $947.16M.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.06B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $899.75M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $673.79M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $947.16M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.05B 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $1.24B 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.02B 10-K · filed 2026-02-25 | |
| 2024-09-30 | $1.37B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.44B 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.57B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $942.46M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.35B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.42B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.00B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $492.36M 10-K · filed 2024-02-27 | $497.57M 10-K · filed 2023-03-01 |
| 2022-09-30 | $637.73M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $607.63M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $571.87M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $293.41M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $342.50M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $338.36M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $288.83M 10-Q · filed 2021-05-26 | |
| 2020-12-31 | $144.56M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |